🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

🧪

Trial Match

Clinical trials test new treatments — sometimes the newest options available for a disease. Find trials that are recruiting now, near you. Open one to see its eligibility rules as simple questions to go through with your doctor.

Know your stage or your test results (such as EGFR, HER2 or BRCA)? Match trials to your own profile - nothing you type is saved.

🎯 Match trials to me

24 recruiting trials

for Hereditary Breast and Ovarian Cancer

18F-T2 PET/CT Imaging for CAIX Positive Solid Tumors NCT07557225NA1 site📍 Beijing Peking University First Hospital · Tests: 18F-T2 PET/CT A Study to Evaluate ARV-6723 Alone and With Pembrolizumab in Participants With Advanced Solid Tumors NCT07749586Phase 1, Phase 24 sites📍 New York📍 Huntersville📍 San Antonio Arvinas Inc. · Tests: ARV-6723, Pembrolizumab, SOC EHR Intervention to Increase HBOC Genetic Testing NCT07876349NA1 site📍 New York Columbia University · Tests: ELISABETH Evidence-Informed Program (EIP) Clinical Validation of the Role of microRNA Binding Site Mutations in Cancer Risk, Prevention and Treatment NCT02253251n/a1 site📍 Los Angeles MiraKind · Tests: KRAS-variant and microRNA binding site mutation testing Integrated Cancer Repository for Cancer Research NCT02012699n/a42 sites📍 Greenwood Village📍 Manchester📍 Daytona Beach University of Nebraska Familial Investigations of Childhood Cancer Predisposition NCT03050268n/a1 site📍 Memphis St. Jude Children's Research Hospital CfDNA in Hereditary And High-risk Malignancies 2 NCT06726642n/a8 sites📍 Vancouver📍 St. John's📍 Halifax University Health Network, Toronto · Tests: Cell-free DNA analysis CONTIGO - A Narrative Intervention to Enhance Genetic Counseling and Testing NCT05130606NA2 sites📍 Washington D.C.📍 Richmond Georgetown University · Tests: Culturally Targeted Narrative Video: "Is My Cancer Hereditary? Rosa Visits a Genetic Counselor.", FORCE Fact … Identifying and Caring for Individuals With Inherited Cancer Syndrome NCT04494945NA2 sites📍 Portland📍 Portland OHSU Knight Cancer Institute · Tests: Biospecimen Collection, Genetic Counseling, Genetic Testing, Survey Administration First-in-Human Study of Tersolisib (STX-478) as Monotherapy and in Combination With Other Antineoplastic Agents in Participants With Advanced Solid Tumors NCT05768139Phase 1, Phase 265 sites📍 Los Angeles📍 San Francisco📍 Aurora Eli Lilly and Company · Tests: STX-478, Fulvestrant, Ribociclib, Palbociclib, Letrozole Population Based Germline Testing for Early Detection and Prevention of Cancer NCT07498829NA1 site📍 London Queen Mary University of London · Tests: Genetic testing for Cancer Susceptibility Genes (CSGs) (BRCA1, BRCA2, RAD51C, RAD51D, BRIP1, PALB2, MLH1, MSH2, MSH6) a… Specimen and Data Study for Ovarian Cancer Early Detection and Prevention NCT00005095n/a1 site📍 Chicago Northwestern University · Tests: Ca-125, screening questionnaire administration, Surgery Pancreatic Cancer Genetics NCT01102569n/a1 site📍 New York Columbia University A Bidirectional Cohort Study on Prophylactic Resection Surgery in Populations at Moderate-to-High Risk for Hereditary Ovarian Cancer NCT07532434n/a1 site📍 Beijing Peking University Third Hospital COsegregation of VARiants in Panel of Genes NCT01689584NA62 sites📍 Bastia📍 Saint-Cloud📍 Amiens Institut Curie · Tests: salivary kit Phase 1/2 Study of ETX-636 in Participants With Advanced Solid Tumors NCT06993844Phase 1, Phase 215 sites📍 Newport Beach📍 San Francisco📍 New Haven Ensem Therapeutics · Tests: ETX-636 dose escalation, ETX-636 dose escalation in combination with fulvestrant, ETX-636 dose expansion in combination… Cascade Genetic Testing for Hereditary Breast/Ovarian Cancer and Lynch Syndrome in Switzerland NCT03124212n/a9 sites📍 Fribourg📍 Geneva📍 Delémont University of Basel · Tests: CASCADE genetic screening The FYI on MRI: A Multilevel Decision Support Intervention for Screening Breast MRI NCT06892275NA1 site📍 Washington D.C. Georgetown University · Tests: Enhanced Usual Care, Decision Support Genetic Predisposition to Breast and Ovarian Cancer: Prospective Study of BRCAx Gene Mutation NCT03667417n/a1 site📍 Marseille Institut Paoli-Calmettes · Tests: Questionnaires Identifying Underserved Individuals inTexas With Hereditary Cancer Risk Using Mobile Mammography Units and Telegenetics. NCT05649072NA1 site📍 Houston M.D. Anderson Cancer Center · Tests: Genetic Testing and Counseling, Screening Form Triple Negative Breast Cancer and Germline Hereditary Breast and Ovarian Cancer Mutation Carrier Registry NCT02302742n/a11 sites📍 Hays📍 Kansas City📍 Overland Park University of Kansas Medical Center Development and Validation of an Ovarian Cancer Risk Prediction Model for Family Members of Ovarian Cancer Probands NCT07039552n/a1 site📍 Beijing Peking University Third Hospital · Tests: risk-reducing salpingo-oophorectomy (RRSO) Liquid Biopsy Evaluation and Repository Development at Princess Margaret NCT03702309n/a1 site📍 Toronto University Health Network, Toronto Developing New Educational Materials About Genetic Testing for a Diverse Group of Cancer Patients NCT04751435NA4 sites📍 Brooklyn📍 Jamaica📍 New York Memorial Sloan Kettering Cancer Center · Tests: Cognitive interview, LCAM intervention, Standard of care
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy